Antiviral drugs

InformationAciclovir (BW 248U) Acyclovir (BW 248U, Acyclovir, Acycloguanosine, Zovirax, ACV, NSC 645011) is a synthetic nucleoside analogue active against herpesviruses. Acyclovir induces cell cycle perturbation and apoptosis in Jurkat leukemia

Aciclovir is a synthetic nucleoside analogue active against herpesviruses.An antiviral compound that can be used to induce apoptosis.

Aciclovir is a synthetic nucleoside analogue active against herpesviruses.An antiviral compound that can be used to induce apoptosis.

Aciclovir is a synthetic nucleoside analogue active against herpesviruses.An antiviral compound that can be used to induce apoptosis.

Aciclovir is a synthetic nucleoside analogue active against herpesviruses.An antiviral compound that can be used to induce apoptosis.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Recommended for the isolation of Enterohemorrhagic E.coli (EHEC).

Acycloguanosine or acyclovir is a guanosine analog. Application Acycloguanosine has been used as an inhibitor of herpes simplex virus type I: to serve as a positive control to compare the antiviral activities of mushroom extracts in cytotoxic

Acycloguanosine or acyclovir is a guanosine analog. Application Acycloguanosine has been used as an inhibitor of herpes simplex virus type I: to serve as a positive control to compare the antiviral activities of mushroom extracts in cytotoxic

Acycloguanosine or acyclovir is a guanosine analog. Application Acycloguanosine has been used as an inhibitor of herpes simplex virus type I: to serve as a positive control to compare the antiviral activities of mushroom extracts in cytotoxic

Acyclovir is a nucleoside analogue antiviral drug. It is a highly potent inhibitor of herpes simplex virus.

Acyclovir Monophosphate is a nucleoside analog phosphates for topical use in treating herpes virus infections. A topical treatment that seems to bypass a key mechanism responsible for resistance to Acyclovir.